ArticleFrontiers in oncology2022

Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepatocellular Carcinoma.

Jia Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.